- Markets
- Agriculture
- NATHBIOGEN
NATHBIOGEN
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Jain Irrigation gains on deal with Indian Coffee Board
** Jain Irrigation JAIR.NS shares jump 4.6%
** Co signs deal with India's Coffee Board to sell "disease-resistant" coffee plants
** Stock up 4.23% this week, on track to snap three weeks of losses
** JAIR up 5.1% YTD, worst performer so far among listed agri companies
** Nath Bio-Genes NATB.NS up 11% YTD, Mangalam Seeds MGSL.BO up 18%, Kaveri Seed KVRI.NS up 84% and JK Agri JKAG.BO up 42% YTD
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
** Jain Irrigation JAIR.NS shares jump 4.6%
** Co signs deal with India's Coffee Board to sell "disease-resistant" coffee plants
** Stock up 4.23% this week, on track to snap three weeks of losses
** JAIR up 5.1% YTD, worst performer so far among listed agri companies
** Nath Bio-Genes NATB.NS up 11% YTD, Mangalam Seeds MGSL.BO up 18%, Kaveri Seed KVRI.NS up 84% and JK Agri JKAG.BO up 42% YTD
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
Nath Bio-Genes (I) June-Quarter Consol Net Profit At 333.5 Million Rupees
Aug 7 (Reuters) - Nath Bio-Genes (I) Ltd NATB.NS:
JUNE-QUARTER CONSOL NET PROFIT 333.5 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.44 BILLION RUPEES
Further company coverage: NATB.NS
(([email protected];))
Aug 7 (Reuters) - Nath Bio-Genes (I) Ltd NATB.NS:
JUNE-QUARTER CONSOL NET PROFIT 333.5 MILLION RUPEES
JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.44 BILLION RUPEES
Further company coverage: NATB.NS
(([email protected];))
India's Nath Bio-Genes (I) June-Quarter Consol Net Profit Rises
Aug 10 (Reuters) - Nath Bio-Genes (I) Ltd NATB.NS:
INDIA'S NATH BIO-GENES (I) JUNE-QUARTER CONSOL NET PROFIT 331.8 MILLION RUPEES VERSUS PROFIT 307.6 MILLION RUPEES
NATH BIO-GENES (I) LTD JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.35 BILLION RUPEES VERSUS 2.09 BILLION RUPEES
Source text for Eikon: ID:nBSE1vmtWL
Further company coverage: NATB.NS
(([email protected];))
Aug 10 (Reuters) - Nath Bio-Genes (I) Ltd NATB.NS:
INDIA'S NATH BIO-GENES (I) JUNE-QUARTER CONSOL NET PROFIT 331.8 MILLION RUPEES VERSUS PROFIT 307.6 MILLION RUPEES
NATH BIO-GENES (I) LTD JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.35 BILLION RUPEES VERSUS 2.09 BILLION RUPEES
Source text for Eikon: ID:nBSE1vmtWL
Further company coverage: NATB.NS
(([email protected];))
Upcoming Events:
Quarterly Results
Events:
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Nath Bio-Genes do?
Nath Bio-Genes is a leading seed company in India with a focus on research and development. They offer a wide range of products in major field crops, vegetables, and bio-stimulants, and have received ISO 9001 certification.
Who are the competitors of Nath Bio-Genes?
Nath Bio-Genes major competitors are JK Agri Genetics, Shree Oswal Seeds, Shree Ganesh BioTech, Bombay Super Hybrid, Kaveri Seed, Uma Expo, Riddhi Siddhi Gluco. Market Cap of Nath Bio-Genes is ₹319 Crs. While the median market cap of its peers are ₹284 Crs.
Is Nath Bio-Genes financially stable compared to its competitors?
Nath Bio-Genes seems to be less financially stable compared to its competitors. Altman Z score of Nath Bio-Genes is 2.61 and is ranked 6 out of its 8 competitors.
Does Nath Bio-Genes pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Nath Bio-Genes latest dividend payout ratio is 9.59% and 3yr average dividend payout ratio is 10.22%
How has Nath Bio-Genes allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Nath Bio-Genes balance sheet?
Balance sheet of Nath Bio-Genes is moderately strong.
Is the profitablity of Nath Bio-Genes improving?
Yes, profit is increasing. The profit of Nath Bio-Genes is ₹39.74 Crs for TTM, ₹39.62 Crs for Mar 2024 and ₹35.03 Crs for Mar 2023.
Is the debt of Nath Bio-Genes increasing or decreasing?
Yes, The debt of Nath Bio-Genes is increasing. Latest debt of Nath Bio-Genes is ₹125 Crs as of Sep-24. This is greater than Mar-24 when it was -₹44.45 Crs.
Is Nath Bio-Genes stock expensive?
Nath Bio-Genes is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Nath Bio-Genes is 8.02, while 3 year average PE is 7.98. Also latest EV/EBITDA of Nath Bio-Genes is 8.34 while 3yr average is 10.88.
Has the share price of Nath Bio-Genes grown faster than its competition?
Nath Bio-Genes has given lower returns compared to its competitors. Nath Bio-Genes has grown at ~-11.6% over the last 3yrs while peers have grown at a median rate of 8.53%
Is the promoter bullish about Nath Bio-Genes?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Nath Bio-Genes is 45.6% and last quarter promoter holding is 45.6%.
Are mutual funds buying/selling Nath Bio-Genes?
The mutual fund holding of Nath Bio-Genes is decreasing. The current mutual fund holding in Nath Bio-Genes is 3.89% while previous quarter holding is 4.37%.